Author:
Bengala C,Danesi R,Guarneri V,Pazzagli I,Donati S,Favre C,Fogli S,Biadi O,Innocenti F,Del Tacca M,Mariani M,Conte P F
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference23 articles.
1. Stadtmauer EA, O'Neill A, Goldstein LJ et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hemopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 2000; 342: 1069–1076.
2. Lotz J-P, Curè H, Janvier M et al. High-dose chemotherapy (HD-CT) with hematopoietic stem cell transplantation (HSCT) for metastatic breast cancer (MBC): results of the French Protocol PEGASE 04. Proc Am Soc Clin Oncol 1999; 18: 43a (abstr. 161).
3. Crump M, Gluck S, Stewart D et al. A randomized trial of high-dose chemotherapy (HDC) with autologous peripheral blood stem cell support (ASCT) compared to standard therapy in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trial group study. Proc Am Soc Clin Oncol. 2001; 20: (abstr. 82).
4. Berg J, Wiklund T, Erikstein B et al. Tailored fluorouracil, epirubicin and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomized trial. Scandinavian Breast Group 9401 study. Lancet 2000; 356: 1384–1391.
5. Teicher B, Cucchi C, Lee J et al. Alkylating agents. In vitro studies of cross-resistance patterns in human tumor cell lines. Cancer Res 1986; 46: 4379–4383.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献